443 related articles for article (PubMed ID: 25791708)
1. Vestibular Schwannoma Excision in Sporadic versus Neurofibromatosis Type 2 Populations.
Mahboubi H; Maducdoc MM; Yau AY; Ziai K; Ghavami Y; Badran KW; Al-Thobaiti M; Brandon B; Djalilian HR
Otolaryngol Head Neck Surg; 2015 Nov; 153(5):822-31. PubMed ID: 25791708
[TBL] [Abstract][Full Text] [Related]
2. Complications of surgery for sporadic vestibular schwannoma.
Mahboubi H; Ahmed OH; Yau AY; Ahmed YC; Djalilian HR
Otolaryngol Head Neck Surg; 2014 Feb; 150(2):275-81. PubMed ID: 24201062
[TBL] [Abstract][Full Text] [Related]
3. Trends in demographics, charges, and outcomes of patients undergoing excision of sporadic vestibular schwannoma.
Ahmed OH; Mahboubi H; Lahham S; Pham C; Djalilian HR
Otolaryngol Head Neck Surg; 2014 Feb; 150(2):266-74. PubMed ID: 24091426
[TBL] [Abstract][Full Text] [Related]
4. Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.
Kruyt IJ; Verheul JB; Hanssens PEJ; Kunst HPM
J Neurosurg; 2018 Jan; 128(1):49-59. PubMed ID: 28128697
[TBL] [Abstract][Full Text] [Related]
5. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
[TBL] [Abstract][Full Text] [Related]
6. NF2 genetic alterations in sporadic vestibular schwannomas: clinical implications.
Lassaletta L; Torres-Martín M; Peña-Granero C; Roda JM; Santa-Cruz-Ruiz S; Castresana JS; Gavilan J; Rey JA
Otol Neurotol; 2013 Sep; 34(7):1355-61. PubMed ID: 23921927
[TBL] [Abstract][Full Text] [Related]
7. Microsurgery for patients diagnosed with neurofibromatosis type 2 complicated by vestibular schwannomas: Clinical experience and strategy for treatments.
Chen LH; Zhang HT; Xu RX; Zhang L; Li WD; Sun K
Medicine (Baltimore); 2018 Apr; 97(17):e0270. PubMed ID: 29702972
[TBL] [Abstract][Full Text] [Related]
8. Facial Nerve Outcomes After Vestibular Schwannoma Microsurgical Resection in Neurofibromatosis Type 2.
Sobieski C; Killeen DE; Barnett SL; Mickey BE; Hunter JB; Isaacson B; Kutz JW
Otolaryngol Head Neck Surg; 2021 Apr; 164(4):850-858. PubMed ID: 32957864
[TBL] [Abstract][Full Text] [Related]
9. Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2.
Choi JW; Lee JY; Phi JH; Wang KC; Chung HT; Paek SH; Kim DG; Park SH; Kim SK
J Neurosurg Pediatr; 2014 Jun; 13(6):650-7. PubMed ID: 24724714
[TBL] [Abstract][Full Text] [Related]
10. Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought.
Evans DG; Moran A; King A; Saeed S; Gurusinghe N; Ramsden R
Otol Neurotol; 2005 Jan; 26(1):93-7. PubMed ID: 15699726
[TBL] [Abstract][Full Text] [Related]
11. Does NF2 status impact the results of combined surgery and adjunctive Gamma Knife surgery for large vestibular schwannomas?
Troude L; Boucekine M; Montava M; Balossier A; Lavieille JP; Régis J; Roche PH
Neurosurg Rev; 2020 Aug; 43(4):1191-1199. PubMed ID: 31388842
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes.
Mallory GW; Pollock BE; Foote RL; Carlson ML; Driscoll CL; Link MJ
Neurosurgery; 2014 Mar; 74(3):292-300; discussion 300-1. PubMed ID: 24335819
[TBL] [Abstract][Full Text] [Related]
13. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
[TBL] [Abstract][Full Text] [Related]
14. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
[TBL] [Abstract][Full Text] [Related]
15. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
Fisher LM; Doherty JK; Lev MH; Slattery WH
Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
[TBL] [Abstract][Full Text] [Related]
16. Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma?
Evans DG; Ramsden RT; Gokhale C; Bowers N; Huson SM; Wallace A
Clin Genet; 2007 Apr; 71(4):354-8. PubMed ID: 17470137
[TBL] [Abstract][Full Text] [Related]
17. Management strategy of vestibular schwannoma in neurofibromatosis type 2.
Odat HA; Piccirillo E; Sequino G; Taibah A; Sanna M
Otol Neurotol; 2011 Sep; 32(7):1163-70. PubMed ID: 21817944
[TBL] [Abstract][Full Text] [Related]
18. Lack of association between human herpesvirus and vestibular schwannoma: analysis of 121 cases.
Bhimrao SK; Maguire J; Garnis C; Tang P; Lea J; Akagami R; Westerberg BD
Otolaryngol Head Neck Surg; 2015 Mar; 152(3):513-7. PubMed ID: 25560404
[TBL] [Abstract][Full Text] [Related]
19. Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2.
Nowak A; Dziedzic T; Czernicki T; Kunert P; Morawski K; Niemczyk K; Marchel A
Neurol Neurochir Pol; 2015; 49(5):295-301. PubMed ID: 26377980
[TBL] [Abstract][Full Text] [Related]
20. Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay.
Yener U; Avsar T; Akgün E; Şeker A; Bayri Y; Kılıç T
J Neurosurg; 2012 Oct; 117(4):697-704. PubMed ID: 22900848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
